Loading...

mosque
partly-cloudy
°C,
العربية
Health - COVID-19

Oxford Biomedica signs new deal to make AstraZeneca COVID shot

July 01, 2022 / 10:46 AM
Image for the title: Oxford Biomedica signs new deal to make AstraZeneca COVID shot
download-img
Sharjah24 - Reuters: Britain's Oxford Biomedica said on Friday it had signed a new three-year agreement to manufacture AstraZeneca's COVID-19 vaccine beyond 2022.
Oxford Biomedica, whose commitments under a previous deal for AstraZeneca's vaccine will end at the end of 2022, said it expected to record about 30 million pounds ($36.4 million) in revenue from the contract in the current financial year.
July 01, 2022 / 10:46 AM

Related Topics

More on this Topic

Image for the title: Moderna to build UK centre for mRNA vaccines
02 years
COVID-19
Moderna to build UK centre for mRNA vaccines
Image for the title: Vaccine supply outstrips demand, access inequity remains
02 years
COVID-19
Vaccine supply outstrips demand, access inequity remains
Image for the title: COVID-19 can cause brain shrinkage, memory loss - study
02 years
Health
COVID-19 can cause brain shrinkage, memory loss - study
Image for the title: Argentina braces for new COVID wave as cases rise to highest
02 years
COVID-19
Argentina braces for new COVID wave as cases rise to highest

Rotate For an optimal experience, please
rotate your device to portrait mode.